2023 - Research.com Microbiology in United Kingdom Leader Award
Brian J. Lipworth spends much of his time researching Asthma, Internal medicine, Anesthesia, Placebo and Endocrinology. His research integrates issues of Methacholine and Allergy in his study of Asthma. The Internal medicine study which covers Gastroenterology that intersects with Respiratory disease, Exhalation and Receiver operating characteristic.
The study incorporates disciplines such as Salbutamol, Ipratropium bromide, Montelukast and Drug tolerance in addition to Anesthesia. His studies deal with areas such as Morning, Inhalation, Salmeterol and Lung volumes as well as Placebo. The Corticosteroid study combines topics in areas such as Hydrocortisone and Triamcinolone acetonide.
Brian J. Lipworth mainly focuses on Internal medicine, Asthma, Anesthesia, Endocrinology and Placebo. His Internal medicine research incorporates themes from Gastroenterology and Cardiology. His Asthma study is concerned with the field of Immunology as a whole.
He has researched Anesthesia in several fields, including Crossover study, Salbutamol and Bronchodilator. The concepts of his Endocrinology study are interwoven with issues in Agonist and Beta. His Placebo study frequently links to adjacent areas such as Montelukast.
Internal medicine, Asthma, Anesthesia, COPD and Spirometry are his primary areas of study. His Internal medicine research is multidisciplinary, relying on both Physical therapy and Cardiology. His work deals with themes such as Gastroenterology, Methacholine and Crossover study, which intersect with Asthma.
His Anesthesia research integrates issues from Placebo and Salbutamol. His work carried out in the field of COPD brings together such families of science as Pulmonary hypertension, Intensive care medicine, Clinical endpoint, Hazard ratio and Bronchodilator. His Corticosteroid study combines topics in areas such as Small airways, Immunology and Genotype.
His scientific interests lie mostly in Asthma, Internal medicine, Anesthesia, Spirometry and COPD. The various areas that he examines in his Asthma study include Methacholine and Clinical trial. His Internal medicine research includes elements of Gastroenterology and Cardiology.
His Anesthesia study incorporates themes from Salbutamol and Asthma Control Questionnaire. His Spirometry study combines topics from a wide range of disciplines, such as Physical therapy, Vital capacity, Airway resistance and Clinical significance. He interconnects Pulmonary disease, Randomized controlled trial, Retrospective cohort study, Severity of illness and Bronchodilator in the investigation of issues within COPD.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Allergic Rhinitis and its Impact on Asthma (ARIA): Achievements in 10 years and future needs
J. Bousquet;H. J. Schünemann;B. Samolinski;P. Demoly.
The Journal of Allergy and Clinical Immunology (2012)
Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen)
J. Bousquet;N. Khaltaev;A. A. Cruz;J. Denburg.
Systemic Adverse Effects of Inhaled Corticosteroid Therapy: A Systematic Review and Meta-analysis
Brian J. Lipworth.
JAMA Internal Medicine (1999)
Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19.
Tobias Herold;Vindi Jurinovic;Chiara Arnreich;Brian J. Lipworth.
The Journal of Allergy and Clinical Immunology (2020)
Phosphodiesterase-4 inhibitors for asthma and chronic obstructive pulmonary disease
Brian J Lipworth.
The Lancet (2005)
Respiratory symptoms, pulmonary function, and markers of inflammation among bar workers before and after a legislative ban on smoking in public places.
Daniel Menzies;Arun Nair;Peter A. Williamson;Stuart Schembri.
Association between β2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics
Soong Tan;Ian P Hall;Jane Dewar;Eleanor Dow.
The Lancet (1997)
Effect of β blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study
Philip M Short;Samuel I W Lipworth;Douglas H J Elder;Stuart Schembri.
Reduced protection against exercise induced bronchoconstriction after chronic dosing with salmeterol
L. Ramage;B.J. Lipworth;C.G. Ingram;I.A. Cree.
Respiratory Medicine (1994)
Brian J Lipworth.
The Lancet (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: